Bicycle Therapeutics, Cancer Research UK collaborate on new immuno-oncology candidate development

This article was originally published here

Claimed to be the world’s largest independent funder of cancer research, Cancer Research UK will provide funding for the exploratory development of Bicycle’s BT7401 candidate through a phase

The post Bicycle Therapeutics, Cancer Research UK collaborate on new immuno-oncology candidate development appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply